已收盘 02-06 16:00:00 美东时间
+1.780
+1.06%
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46
Barrington Research analyst Alexander Paris maintains Grand Canyon Education (NASDAQ:LOPE) with a Outperform and maintains $230 price target.
01-22 20:43
Grand Canyon Education ( ($LOPE) ) just unveiled an update. On December 12, 202...
2025-12-15 22:25
The decision brings ED's classification into alignment with every other governmental and accrediting authority that previously affirmed GCU's nonprofit status — including the IRS, Higher Learning Commission (HLC), State
2025-12-15 21:06
Grand Canyon Education ( ($LOPE) ) has shared an update. Grand Canyon Education...
2025-10-31 05:47
今日重点评级关注:Guggenheim:维持MBX Biosciences"买入"评级,目标价从44美元升至84美元;Oppenheimer:维持MBX Biosciences"跑赢大市"评级,目标价从38美元升至80美元
2025-09-24 10:23
Barrington Research analyst Alexander Paris maintains Grand Canyon Education (NASDAQ:LOPE) with a Outperform and maintains $230 price target.
2025-09-23 23:06
The government’s lawsuit against Grand Canyon University (NASDAQ:LOPE) and its president has been dismissed as all parties involved in the case filed a joint Stipulation of Dismissal with Prejudice wi...
2025-08-18 22:54